NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

Indian Equity Benchmarks Post Gains on Monday

The Indian stock market concluded the session on a positive note on Monday, 4 May, with the Nifty 50 index experiencing a notable increase. The Nifty 50 rose by 121.75 points, representing a 0.51% rise, to close at 24,119.30. This upward momentum was mirrored in the Sensex, which gained 355.90 points, or 0.46%, to finish at 77,269.40.

The advance was driven by broad-based buying, with a significant advance-decline ratio of 2,140:1,187. This ratio indicates strong participation from mid- and small-cap stocks, suggesting a healthy appetite among investors for these segments. The market's overall performance on Monday was characterized by a robust gain, driven by the collective buying activity of investors across various segments of the market.

Read also: Treasury Yields Experience Largest Increase in Two Weeks Following Release of Labor Market Data

Investor Takeaway

Investors should focus on broad-based buying and participation from mid- and small-cap stocks.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.